Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Tullis-Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
University of California Irvine Medical Center
Los Alamitos, California
Manager, Editorial Operations
Senior Clinical Editor
Associate Director, Scientific Services
The target audience for these activities are endocrinologists (including MD, DO, NP, and PA) primary care clinicians (including MD, DO, NP and PA), and other healthcare providers who are part of the diabetes care team including nurses, certified diabetes educators, pharmacists, and registered dieticians.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This program provides 0.25 contact hour of continuing education credit.
Provider approved by the California Board of Registered Nursing, Provider # 10977, for 0.25 Contact Hour. RNs must retain this document for 4 years after the activity concludes
The Association of Diabetes Care & Education Specialists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.25 contact hours (.025 CEU's) of continuing education credit.
ACPE Universal Activity Number: 0069-9999-20-037-H01-P
Type of Activity: Knowledge
This program has been made available online.
Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 20, 2020, through March 19, 2021:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Concise CCO expert commentary on potential side effects with GLP-1 receptor agonists in patients with type 2 diabetes
Neil Skolnik, MD reviews GLP-1 RAs to address elevated A1C, obesity, and CV risk, plus strategies to improve tolerability, adherence
Hyperglycemia can be a deadly complication for anyone with diabetes, but there are tools that can reduce this risk including GLP-1 medications. Learn more today.
CME commentary: GLP-1 receptor agonists to prevent major cardiovascular adverse events (MACE) in type 2 diabetes (T2D), cardiovascular disease (CVD)
For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.